GO:0031214 biomineral tissue development: Calcification Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031214 biomineral tissue development describes the formation of hard tissues that consist mainly of inorganic compounds together with small amounts of organic matrix that are believed to play important roles in their formation.
• The process underlies physiological mineralization of bone, teeth and other hard tissues, and its dysregulation produces pathological calcification in soft tissues, including calcinosis, calciphylaxis and nephrocalcinosis.
• Ectopic calcification can occur in diverse anatomical sites such as skin, subcutaneous tissue, kidneys and the central nervous system.
• Cerebral calcification and intracranial calcifications are recognized manifestations of disturbed biomineral tissue development in the nervous system.
• The organic matrix of mineralized tissue is considered essential for directing and regulating the deposition of inorganic mineral.
• Experimental study of biomineral tissue development requires integration of histological, biochemical and genetic approaches to distinguish physiological from pathological mineralization.
Description
Biomineral tissue development (GO:0031214) is the biological process by which hard tissues are formed from predominantly inorganic compounds together with a small organic matrix that is believed to play important roles in their formation. This process is fundamental to the normal development and maintenance of mineralized tissues, and its disturbance is associated with a wide range of clinical calcification disorders. Early studies of calcification established that mineral deposition is not a passive physicochemical event but a biologically regulated process in which the organic matrix participates actively. The term therefore encompasses both physiological hard-tissue formation and the pathological deposition of mineral in soft tissues, which has been documented in conditions such as calcinosis, calciphylaxis and nephrocalcinosis. Because ectopic calcification can affect nearly every organ system, including the skin, kidneys and brain, understanding the mechanisms of biomineral tissue development is of broad biomedical importance. Research into this process continues to inform the diagnosis and management of calcific diseases and to guide the development of experimental models for studying mineralization.
biomineral tissue development At A Glance
| GO ID | GO:0031214 |
|---|---|
| GO term | biomineral tissue development |
| Ontology | biological_process |
| Synonym | none |
| Definition | Formation of hard tissues that consist mainly of inorganic compounds, and also contain a small amounts of organic matrices that are believed to play important roles in their formation. |
| Major function | Deposition of inorganic mineral within an organic matrix to form hard tissues |
| Associated pathology | Calcinosis, calciphylaxis, nephrocalcinosis and intracranial calcification |
| Organic matrix role | The organic matrix is believed to play important roles in mineral formation |
| Research relevance | Provides a framework for studying physiological and pathological mineralization |
What Is GO:0031214?
GO:0031214 biomineral tissue development is defined as the formation of hard tissues that consist mainly of inorganic compounds, and also contain small amounts of organic matrices that are believed to play important roles in their formation. In other words, it is the biologically controlled deposition of mineral into an organic scaffold, producing hard tissues such as bone and other mineralized structures, and it is distinguished from purely physicochemical precipitation by the participation of an organic matrix.
Why Is biomineral tissue development Important in Cell Biology?
Biomineral tissue development is important because it governs the formation of hard tissues and, when dysregulated, produces pathological calcification in soft tissues that can cause significant morbidity. The process has been linked to calcinosis, calciphylaxis, nephrocalcinosis and intracranial calcification, indicating that it is relevant to dermatology, nephrology, neurology and general medicine. Understanding how the organic matrix controls mineral deposition is therefore central to both basic biology and clinical practice.
• Defines the biological process responsible for forming hard tissues from inorganic compounds and organic matrix.
• Explains the pathogenesis of calcinosis, a condition characterized by abnormal mineral deposition.
• Underlies calciphylaxis, a serious disorder of soft-tissue calcification.
• Contributes to nephrocalcinosis, in which mineral deposits form in the kidney.
• Is implicated in intracranial and cerebral calcification syndromes.
• Highlights the regulatory role of the organic matrix in mineral formation.
• Provides a conceptual basis for distinguishing physiological from pathological mineralization.
• Supports research into therapeutic strategies for calcific diseases.
• Connects basic mineralization biology to clinical specialties such as dermatology, nephrology and neurology.
• Guides the design of experimental models for studying ectopic calcification.
What Happens During biomineral tissue development?
Initiation of mineral deposition
In simple terms: The process starts when the body begins to lay down mineral in a tissue.
Biomineral tissue development begins with the initiation of mineral deposition within a tissue environment that contains an organic matrix. Early concepts of calcification emphasized that this initiation is not a random event but is influenced by the local biochemical milieu and the presence of organic components that are believed to play important roles in the formation of hard tissues.
Role of the organic matrix
In simple terms: The organic matrix acts like a scaffold that helps control how mineral is deposited.
The organic matrix of mineralized tissues is believed to play important roles in their formation, and it is considered essential for directing the deposition of inorganic mineral. This matrix provides a structural and regulatory framework that distinguishes biologically controlled biomineral tissue development from simple physicochemical precipitation.
Formation of hard tissue
In simple terms: Mineral and matrix combine to create a hard tissue.
As mineral deposition proceeds within the organic matrix, hard tissues are formed that consist mainly of inorganic compounds together with small amounts of organic matrix. This step represents the culmination of biomineral tissue development and produces the mineralized structures characteristic of the process.
Pathological calcification in soft tissues
In simple terms: When the process goes wrong, mineral can deposit in places where it should not, such as skin or kidneys.
When biomineral tissue development occurs inappropriately in soft tissues, it results in pathological calcification, including calcinosis, calciphylaxis and nephrocalcinosis. These conditions demonstrate that the same process that forms hard tissues can cause disease when it is misdirected or dysregulated.
Calcification in the central nervous system
In simple terms: Mineral can also deposit in the brain, causing intracranial calcification.
Biomineral tissue development can also occur in the central nervous system, where it manifests as intracranial or cerebral calcification. Such calcification has been described in association with cerebral tuberculoma and other intracranial lesions, indicating that the process can be triggered in diverse pathological contexts.
Key Genes Involved in GO:0031214 biomineral tissue development
The following genes and proteins have been implicated in biomineral tissue development and related calcification disorders based on the published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Organic matrix components | Provide the organic scaffold for mineral deposition | Studied to understand how matrix regulates hard tissue formation |
| Mineral-binding proteins | Interact with inorganic mineral during deposition | Targets for investigating initiation of calcification |
| Matrix regulatory factors | Modulate the organic matrix during biomineral tissue development | Relevant to distinguishing physiological from pathological mineralization |
| Calcium-regulatory proteins | Influence calcium availability for mineral formation | Linked to calcinosis and nephrocalcinosis |
| Phosphate-regulatory proteins | Contribute to inorganic compound deposition | Studied in ectopic calcification models |
| Inflammatory mediators | Associated with calciphylaxis and soft-tissue calcification | Potential targets in calciphylaxis research |
| Renal transport proteins | Involved in nephrocalcinosis | Models for kidney mineral deposition |
| CNS calcification factors | Associated with intracranial calcification | Relevant to cerebral calcification research |
| Tuberculoma-associated factors | Linked to cerebral calcification in tuberculoma | Model for infection-associated calcification |
| Dermal matrix proteins | Involved in calcinosis of the skin | Studied in dermatological calcification |
| Generalized calcinosis factors | Contribute to widespread mineral deposition | Relevant to systemic calcification disorders |
| Calcification inhibitors | Believed to prevent inappropriate mineralization | Potential therapeutic targets |
| Calcification promoters | Facilitate mineral deposition in tissues | Studied to understand ectopic calcification |
| Matrix vesicles | Serve as sites of initial mineral formation | Experimental models for initiation studies |
| Collagenous matrix proteins | Provide structural framework for hard tissue | Relevant to hard tissue engineering research |
| Non-collagenous matrix proteins | Regulate mineral deposition within matrix | Targets for functional studies |
How Is biomineral tissue development Regulated?
Biomineral tissue development is regulated by the organic matrix, which is believed to play important roles in the formation of hard tissues and in controlling mineral deposition. The process can be triggered in diverse pathological contexts, including soft-tissue calcification, renal calcification and intracranial calcification, indicating that local tissue factors influence whether mineralization occurs. The balance between factors that promote and inhibit mineralization is therefore considered critical for determining whether biomineral tissue development proceeds normally or pathologically.
biomineral tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Organic matrix components | Calcinosis | Knockout of matrix genes in mineralizing cells |
| Matrix regulatory factors | Calciphylaxis | Point mutation to alter matrix regulation |
| Renal transport proteins | Nephrocalcinosis | Knock-in of disease-associated variants |
| CNS calcification factors | Intracranial calcification | Overexpression in neuronal models |
| Calcification inhibitors | Generalized calcification | Knockout to induce ectopic mineralization |
Calcinosis and calciphylaxis
Calcinosis is a condition characterized by abnormal deposition of mineral in tissues, reflecting dysregulated biomineral tissue development. Calciphylaxis is a related disorder of soft-tissue calcification that can be severe and is associated with significant morbidity. These conditions illustrate how the process of biomineral tissue development can become pathological when it occurs in inappropriate locations.
Nephrocalcinosis
Nephrocalcinosis refers to the deposition of mineral in the kidney and represents a renal manifestation of disturbed biomineral tissue development. The condition has been recognized as a distinct clinical entity and is studied as a model of ectopic calcification in the urinary system.
Intracranial and cerebral calcification
Intracranial calcifications and cerebral calcification are manifestations of biomineral tissue development in the central nervous system. Cerebral tuberculoma has been associated with calcification, indicating that infectious and inflammatory processes can trigger mineralization in the brain. These conditions are important because they can be detected radiologically and may reflect underlying neurological disease.
Generalized calcification disorders
Generalized calcinosis has been described as a condition affecting multiple sites, demonstrating that biomineral tissue development can be systemically dysregulated. Such disorders highlight the need for research into the mechanisms that normally restrict mineralization to hard tissues.
From biomineral tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a matrix gene cause ectopic calcification? | Knockout cell model |
| Does a specific point mutation alter mineral deposition? | Point-mutation knock-in |
| Can a disease-associated variant reproduce calcification? | Knock-in of patient variant |
| Where is a matrix protein localized during mineralization? | Tagged knock-in |
| Does overexpression of a factor promote calcification? | Overexpression cell model |
| Which genes regulate biomineral tissue development? | CRISPR library screening |
How to Study the biomineral tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histology | Presence and distribution of mineral deposits | Diagnosis of calcinosis and intracranial calcification |
| Imaging | Radiological evidence of calcification | Detection of cerebral calcification |
| Biochemical assay | Inorganic and organic composition of mineralized tissue | Analysis of hard tissue formation |
| Genetic analysis | Variants in genes related to mineralization | Study of calcification disorders |
| Molecular biology | Expression of matrix and regulatory factors | Functional studies of biomineral tissue development |
| Clinical observation | Spectrum of calcification phenotypes | Characterization of calcific diseases |
| Epidemiological study | Distribution of calcification disorders | Population-level research on nephrocalcinosis |
Histological and imaging methods
Histological examination and imaging are used to detect mineral deposits in tissues and to characterize the distribution of calcification in conditions such as calcinosis, nephrocalcinosis and intracranial calcification. These methods are essential for confirming the presence of biomineral tissue development in experimental and clinical samples.
Biochemical analysis of mineral and matrix
Biochemical approaches are used to analyze the inorganic and organic components of mineralized tissues, reflecting the definition of biomineral tissue development as formation of hard tissues consisting mainly of inorganic compounds with small amounts of organic matrix. Such analyses help to distinguish physiological from pathological mineralization.
Genetic and molecular studies
Genetic and molecular studies are employed to identify factors that regulate biomineral tissue development and to test their roles in calcification disorders. These approaches include the study of matrix components and regulatory factors that are believed to play important roles in hard tissue formation.
Clinical and epidemiological observation
Clinical and epidemiological observations have documented calcification disorders such as calcinosis, calciphylaxis and nephrocalcinosis, providing insights into the human relevance of biomineral tissue development. These studies help to define the spectrum of diseases associated with dysregulated mineralization.
How CRISPR Can Be Used to Study GO:0031214 biomineral tissue development
Knockout
CRISPR knockout models can be used to delete genes encoding organic matrix components or regulatory factors to test whether their loss leads to ectopic calcification or defective hard tissue formation, based on the concept that the organic matrix plays important roles in biomineral tissue development.
Point Mutation
Point mutation models allow the introduction of specific amino acid changes into genes implicated in calcification disorders, enabling researchers to test whether a variant alters mineral deposition as observed in calcinosis or nephrocalcinosis.
Knock-in
Knock-in models can be used to insert disease-associated variants or tags into endogenous loci to study their effects on biomineral tissue development and to track protein localization during mineralization.
Overexpression
Overexpression models can be used to increase the levels of factors suspected to promote mineralization, testing whether excess activity drives pathological calcification such as calciphylaxis or generalized calcinosis.
How EDITGENE Supports biomineral tissue development Research
Researchers studying biomineral tissue development-related genes often need to determine whether a candidate gene is causally involved in mineral deposition or whether it is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout and point-mutation models to knock-in, overexpression and library screening, supported by bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for biomineral tissue development research.
Frequently Asked Questions About biomineral tissue development
What is GO:0031214 biomineral tissue development?
GO:0031214 biomineral tissue development is the biological process of forming hard tissues that consist mainly of inorganic compounds and also contain small amounts of organic matrices that are believed to play important roles in their formation.
What genes are involved in biomineral tissue development?
Genes encoding organic matrix components, mineral-binding proteins and matrix regulatory factors are involved in biomineral tissue development, as the organic matrix is believed to play important roles in hard tissue formation.
What diseases are associated with biomineral tissue development?
Diseases associated with this process include calcinosis, calciphylaxis, nephrocalcinosis and intracranial calcification.
How is biomineral tissue development studied?
It is studied using histological, imaging, biochemical, genetic and molecular methods to analyze mineral deposits and the organic matrix.
What is the role of the organic matrix in biomineral tissue development?
The organic matrix is believed to play important roles in the formation of hard tissues and is considered essential for directing mineral deposition.
Can biomineral tissue development occur in soft tissues?
Yes, when it occurs inappropriately in soft tissues it causes pathological calcification such as calcinosis, calciphylaxis and nephrocalcinosis.
What is nephrocalcinosis?
Nephrocalcinosis is the deposition of mineral in the kidney and represents a renal manifestation of disturbed biomineral tissue development.
What is calciphylaxis?
Calciphylaxis is a disorder of soft-tissue calcification that is associated with significant morbidity.
How can CRISPR be used to study biomineral tissue development?
CRISPR can be used to create knockout, point-mutation, knock-in and overexpression models to test the roles of genes in mineral deposition.
Why is biomineral tissue development important for medicine?
It is important because dysregulation leads to calcific diseases affecting the skin, kidneys and brain, making it relevant to multiple clinical specialties.
Conclusion
Biomineral tissue development (GO:0031214) is a fundamental biological process that produces hard tissues from inorganic compounds and a small organic matrix that is believed to play important roles in their formation. Its dysregulation underlies a spectrum of calcific disorders, including calcinosis, calciphylaxis, nephrocalcinosis and intracranial calcification. Continued research using genetic and molecular tools will clarify the mechanisms that control this process and may lead to new strategies for treating pathological calcification.
References
- 1. ANNAMUNTHODO H. 1960. Calcinosis.. Am J Surg 99:951-5 PMID: 13793741
- 2. HOWELL DS. 1963. CONCEPTS OF CALCIFICATION.. Arthritis Rheum 6:736-42 PMID: 14104057
- 3. ROTHMAN S et al.. 1947. Calcinosis, generalized.. Arch Derm Syphilol 55(1):141 PMID: 20283704
- 4. PAILLAS JE et al.. 1957. [Intracranial calcifications].. Presse Med (1893) 65(33):768-71 PMID: 13431833
- 5. NAHUN LH. 1963. CALCIPHYLAXIS.. Conn Med 27:666-9 PMID: 14079259
- 6. PYRAH LN et al.. 1960. Nephrocalcinosis.. Br J Urol 32:361-73 PMID: 13738591
- 7. Unknown. 1959. CALCIFICATION.. Lab Invest 8:1041-4 PMID: 13857388
- 8. CASTRO M et al.. 1963. CEREBRAL TUBERCULOMA.. Acta Radiol Diagn (Stockh) 1:821-7 PMID: 14044716
